Literature DB >> 4296195

Synacthen Depot--Adrenal response in normal subjects and corticotrophin-treated patients.

J K Nelson, D W Neill, D A Montgomery, J S MacKay, B Sheridan, J A Weaver.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4296195      PMCID: PMC1985229          DOI: 10.1136/bmj.1.5591.557

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  EFFECT OF A SYNTHETIC CORTICOTROPHIC POLYPEPTIDE ON ADRENAL FUNCTION IN HYPERSENSITIVE ASTHMATICS.

Authors:  A H EL-SHABOURY
Journal:  Lancet       Date:  1965-02-06       Impact factor: 79.321

2.  A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma.

Authors:  D MATTINGLY
Journal:  J Clin Pathol       Date:  1962-07       Impact factor: 3.411

3.  Intermittent therapy with corticotrophin.

Authors:  J K Nelson; J S Mackay; B Sheridan; J A Weaver
Journal:  Lancet       Date:  1966-07-09       Impact factor: 79.321

  3 in total
  6 in total

1.  Synacthen depot used in general practice.

Authors:  J E Murphy; J F Donald
Journal:  Br Med J       Date:  1969-02-01

2.  Controversies in the treatment of rheumatoid arthritis.

Authors:  O Savage
Journal:  Proc R Soc Med       Date:  1969-02

3.  Tetracosactrin for the management of asthmatic patients after long-term corticosteroids.

Authors:  P Hugh-Jones; R S Pearson; M Booth
Journal:  Thorax       Date:  1975-08       Impact factor: 9.139

4.  Potassium metabolism in patients with rheumatoid arthritis. Effects of treatment with depot tetracosactrin, spironolactone, and oral supplements of potassium chloride.

Authors:  G Nuki; K Boddy; A C Kennedy; P King; A M Duncan; W W Buchanan
Journal:  Ann Rheum Dis       Date:  1975-12       Impact factor: 19.103

5.  Comparison of the adrenocorticotrophic activities of two synthetic polypeptides: synacthen and DW 75.

Authors:  W W Downie; K Whaley; M A Wright; M A Bell; A K Taylor
Journal:  Br Med J       Date:  1968-11-23

6.  Assessment of long-acting synthetic corticotrophin in hypersensitive asthmatics and normal subjects.

Authors:  A H el-Shaboury
Journal:  Br Med J       Date:  1968-09-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.